This result, together with our finding that recombinant WISP1 promoted the growth of MCF-7 and MDA-MB-231 (Fig 1B and 1C) cells, provides the first laboratory evidence, in addition to the human breast cancer specimen data, suggesting that WISP1 acts as an oncogene in human breast cancer. The gene discussed is CCN4; the disease is breast carcinoma.